189 related articles for article (PubMed ID: 7847809)
1. Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cells.
De Filippi R; Prete SP; Giuliani A; Silvi E; Yamaue H; Nieroda CA; Greiner JW; De Vecchis L; Bonmassar E
Anticancer Res; 1994; 14(5A):1767-73. PubMed ID: 7847809
[TBL] [Abstract][Full Text] [Related]
2. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
[TBL] [Abstract][Full Text] [Related]
3. Effect of the combined treatment with 5-fluorouracil, gamma-interferon or folinic acid on carcinoembryonic antigen expression in colon cancer cells.
Aquino A; Prete SP; Greiner JW; Giuliani A; Graziani G; Turriziani M; De Filippi R; Masci G; Bonmassar E; De Vecchis L
Clin Cancer Res; 1998 Oct; 4(10):2473-81. PubMed ID: 9796980
[TBL] [Abstract][Full Text] [Related]
4. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent].
Ohmura K; Tsukamoto T
Hinyokika Kiyo; 1989 May; 35(5):737-47. PubMed ID: 2801371
[TBL] [Abstract][Full Text] [Related]
5. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.
Chu E; Zinn S; Boarman D; Allegra CJ
Cancer Res; 1990 Sep; 50(18):5834-40. PubMed ID: 1697502
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1.
Morikawa K; Fidler IJ
J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665
[TBL] [Abstract][Full Text] [Related]
7. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
[TBL] [Abstract][Full Text] [Related]
8. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
Bjelogrlić SK; Srdić T; Radulović S
J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
[TBL] [Abstract][Full Text] [Related]
9. 5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine.
Correale P; Del Vecchio MT; Di Genova G; Savellini GG; La Placa M; Terrosi C; Vestri M; Urso R; Lemonnier F; Aquino A; Bonmassar E; Giorgi G; Francini G; Cusi MG
J Natl Cancer Inst; 2005 Oct; 97(19):1437-45. PubMed ID: 16204693
[TBL] [Abstract][Full Text] [Related]
10. In vitro modulation of interleukin-2-mediated human peripheral mononuclear cell proliferation and antitumor cytotoxicity by 5-fluorouracil.
Brazowski E; Eytan K; Eisenthal A
Anticancer Res; 2007; 27(6B):4135-41. PubMed ID: 18225584
[TBL] [Abstract][Full Text] [Related]
11. Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate.
Huang Y; Horvath CM; Waxman S
Cancer Res; 2000 Jun; 60(12):3200-6. PubMed ID: 10866311
[TBL] [Abstract][Full Text] [Related]
12. Combined antitumour activity of mitomycin C, 5-fluorouracil and interleukin-2 against human colon cancer cells.
Ishihara M; Kubota T; Watanabe M; Kawano Y; Narai S; Yasui N; Otani Y; Teramoto T; Kitajima M
Anticancer Res; 1999; 19(1A):313-6. PubMed ID: 10226560
[TBL] [Abstract][Full Text] [Related]
13. Genes associated with human hepatocellular carcinoma cell chemosensitivity to 5-fluorouracil plus interferon-alpha combination chemotherapy.
Moriyama M; Hoshida Y; Kato N; Otsuka M; Yoshida H; Kawabe T; Omata M
Int J Oncol; 2004 Nov; 25(5):1279-87. PubMed ID: 15492816
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
[TBL] [Abstract][Full Text] [Related]
15. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.
Chu E; Koeller DM; Johnston PG; Zinn S; Allegra CJ
Mol Pharmacol; 1993 Apr; 43(4):527-33. PubMed ID: 8474431
[TBL] [Abstract][Full Text] [Related]
16. The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha.
Oie S; Ono M; Yano H; Maruyama Y; Terada T; Yamada Y; Ueno T; Kojiro M; Hirano K; Kuwano M
Int J Oncol; 2006 Dec; 29(6):1469-78. PubMed ID: 17088986
[TBL] [Abstract][Full Text] [Related]
17. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
[TBL] [Abstract][Full Text] [Related]
19. New combination of 5-fluorouracil and interferon-gamma effective against human myeloid leukemia in vitro.
Kafka M; Nathan I; Dvilansky A
Anticancer Res; 1989; 9(4):1037-40. PubMed ID: 2510579
[TBL] [Abstract][Full Text] [Related]
20. Combination of 5-FU and IFNalpha enhances IFN signaling pathway and caspase-8 activity, resulting in marked apoptosis in hepatoma cell lines.
Koike K; Takaki A; Tatsukawa M; Suzuki M; Shiraha H; Iwasaki Y; Sakaguchi K; Shiratori Y
Int J Oncol; 2006 Nov; 29(5):1253-61. PubMed ID: 17016659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
